WO2007008937A8 - Adiponectin variants - Google Patents
Adiponectin variantsInfo
- Publication number
- WO2007008937A8 WO2007008937A8 PCT/US2006/026971 US2006026971W WO2007008937A8 WO 2007008937 A8 WO2007008937 A8 WO 2007008937A8 US 2006026971 W US2006026971 W US 2006026971W WO 2007008937 A8 WO2007008937 A8 WO 2007008937A8
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- adiponectin
- variant
- relative
- seq
- adiponectin variants
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/5759—Products of obesity genes, e.g. leptin, obese (OB), tub, fat
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Abstract
An adiponectin variant comprising one or more amino acid modifications relative to a corresponding parent adiponectin, wherein the solubility of said variant is improved by at least 3-fold relative to residues 110-244 of SEQ ID NO:1 (human adiponectin). Said adiponectin variant may not comprise residues 1-100 relative to SEQ ID NO:1.
Applications Claiming Priority (26)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US69835805P | 2005-07-11 | 2005-07-11 | |
US60/698,358 | 2005-07-11 | ||
US72076805P | 2005-09-26 | 2005-09-26 | |
US60/720,768 | 2005-09-26 | ||
US73313705P | 2005-11-02 | 2005-11-02 | |
US60/733,137 | 2005-11-02 | ||
US11/328,901 | 2006-01-09 | ||
PCT/US2006/000627 WO2006074432A2 (en) | 2005-01-07 | 2006-01-09 | Adiponectin variants |
US11/328,901 US20070015909A1 (en) | 2005-01-07 | 2006-01-09 | Adiponectin variants |
USPCT/US2006/000627 | 2006-01-09 | ||
US77782506P | 2006-03-01 | 2006-03-01 | |
US60/777,825 | 2006-03-01 | ||
US78150906P | 2006-03-09 | 2006-03-09 | |
US60/781,509 | 2006-03-09 | ||
US79022006P | 2006-04-07 | 2006-04-07 | |
US60/790,220 | 2006-04-07 | ||
US11/421,055 | 2006-05-30 | ||
US11/421,059 US7709607B2 (en) | 2005-07-11 | 2006-05-30 | Adiponectin variants |
US11/421,060 | 2006-05-30 | ||
US11/421,062 US20070054359A1 (en) | 2005-07-11 | 2006-05-30 | Rational Chemical Modification of Adiponectin Variants |
US11/421,062 | 2006-05-30 | ||
US11/421,055 US7592423B2 (en) | 2005-01-07 | 2006-05-30 | Globular adiponectin variants |
US11/421,059 | 2006-05-30 | ||
US11/421,060 US7749956B2 (en) | 2005-01-07 | 2006-05-30 | Method of treatment using adiponectin variants |
US11/421,061 US7678886B2 (en) | 2005-01-07 | 2006-05-30 | Pharmaceutical compositions of adiponectin variants and methods of storage |
US11/421,061 | 2006-05-30 |
Publications (3)
Publication Number | Publication Date |
---|---|
WO2007008937A2 WO2007008937A2 (en) | 2007-01-18 |
WO2007008937A8 true WO2007008937A8 (en) | 2007-04-12 |
WO2007008937A3 WO2007008937A3 (en) | 2007-05-18 |
Family
ID=37637911
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2006/026971 WO2007008937A2 (en) | 2005-07-11 | 2006-07-11 | Adiponectin variants |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2007008937A2 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2020447A1 (en) | 2007-08-03 | 2009-02-04 | Zeltia, S.A. | Method for identifying compounds modulating adiponectin gene expression |
WO2009025300A1 (en) | 2007-08-21 | 2009-02-26 | Regenetiss Inc. | Peptide capable of binding to immunoglobulin |
CN102294021A (en) * | 2011-07-28 | 2011-12-28 | 山西医科大学 | Medicinal preparation for reducing blood sugar |
CN103031323B (en) * | 2011-09-30 | 2014-10-08 | 浙江大学宁波理工学院 | Glutamate decarboxylase (GAD) thermally-stable variant G56P gene and application thereof |
WO2013130676A1 (en) * | 2012-02-29 | 2013-09-06 | Ambrx, Inc. | Modified adiponectin polypeptides and their uses |
CN112521481B (en) * | 2020-12-08 | 2022-11-04 | 武汉市工程科学技术研究院 | Surface modifier and preparation method and application thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2002358467A1 (en) * | 2001-12-21 | 2003-07-15 | Maxygen Aps | Adiponectin fragments and conjugates |
EP1756159A1 (en) * | 2004-05-21 | 2007-02-28 | Xencor, Inc. | C1q family member proteins with altered immunogenicity |
-
2006
- 2006-07-11 WO PCT/US2006/026971 patent/WO2007008937A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2007008937A3 (en) | 2007-05-18 |
WO2007008937A2 (en) | 2007-01-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2007056362A3 (en) | Glucagon analogs exhibiting physiological solubility and stability | |
IN2014CN02050A (en) | ||
IL182716A0 (en) | Method for purifying fsh | |
EA201170878A1 (en) | POLYPEPTIDES WITH XYLANASE ACTIVITY | |
NZ593050A (en) | Glucagon-like-peptide-2 (glp-2) analogues | |
BRPI0307702B8 (en) | antibody-containing solution formulations | |
WO2007008937A8 (en) | Adiponectin variants | |
WO2007133153A8 (en) | Improved antimicrobial peptides | |
WO2006042745A3 (en) | Chemically modified peptide analogs | |
TW200621160A (en) | Anti-termite agent | |
WO2008054793A3 (en) | Dipterinyl calcium pentahydrate (dcp) and therapeutic methods based thereon | |
CA2527630A1 (en) | Aqueous compositions based on polychloroprene | |
EP1344827A3 (en) | Antifreeze proteins from basidiomycetes | |
WO2005066207A8 (en) | Glucagon-like peptide-1 analogs with long duration of action | |
WO2010057242A3 (en) | Vaccine | |
WO2008047370A3 (en) | Compositions and methods for inducing angiogenesis | |
WO2007015069A3 (en) | Compositions for ameliorating a reduced higher brain function resulting from organic brain lesions | |
AU2003268215A1 (en) | Improved j2ee connector architecture | |
WO2006074432A3 (en) | Adiponectin variants | |
WO2003064452A3 (en) | Method for the preparation of highly branched polypeptides | |
PL376926A1 (en) | Novel 2',5'-oligoadenylic acid analogues | |
AU2003245663A1 (en) | Process for the enzymatic resolution of 1,3-dioxolane-4-carboxylates | |
LT2007062A (en) | Deguoni sugeriantys poliesteriai su prislopintomis pakartotinio panaudojimo spalvomis | |
WO2003035878A3 (en) | Lipase variants | |
AU2003298207A1 (en) | Aqueous acaricidal solution |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase in: |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 06786949 Country of ref document: EP Kind code of ref document: A2 |